e-learning
resources
Milan 2017
Sunday, 10.09.2017
From donor lung selection and organ preservation to lung transplant outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic variation in the STAT3 gene has an impact on survival after lung transplantation
T. Heigl (Leuven, Belgium)
Source:
International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Session:
From donor lung selection and organ preservation to lung transplant outcome
Session type:
Poster Discussion
Number:
1559
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Heigl (Leuven, Belgium). Genetic variation in the STAT3 gene has an impact on survival after lung transplantation. 1559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Up-regulation of γ-glutamyl-cysteine-synthetase gene expression after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001
Genetic variations and lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 525s
Year: 2006
Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Integrated mRNA and miRNA expression profiling of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Gene expression markers to segregate lung transplant rejection phenotypes
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
Polymorphisms in immunosuppression transporters affect outcome after lung transplantation.
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
VEGF gene polymorphisms are associated with post-natal lung function development
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012
Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020
Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Source: Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018
Year: 2019
The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Genetic and environmental factors influencing lung growth and lung function
Source: Eur Respir Mon; 2010: 47: 16–31
Year: 2010
Genetic polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept